Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy? 

Slides:



Advertisements
Similar presentations
A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer  William M. Buckett, M.D.  Fertility and Sterility 
Advertisements

Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion    Fertility and Sterility 
Grace Younes, M.D., Togas Tulandi, M.D., M.H.C.M. 
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Single blastocyst transfer: a prospective randomized trial
Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology.
Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Endometrial integrin expression in women with recurrent implantation failure after in vitro fertilization and its relationship to pregnancy outcome  Carol.
A prospective, randomized, double-blinded study of assisted hatching in women younger than 38 years undergoing in vitro fertilization  Andrea R. Hagemann,
Michael M. Alper, M.D.  Fertility and Sterility 
Ovarian pregnancy after in vitro fertilization
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
A prospective randomized controlled trial of preimplantation genetic screening in the “good prognosis” patient  Liza R. Meyer, M.S., Sigal Klipstein,
Annette Kuhn, M. D. , Doris Bapst, Werner Stadlmayr, M. D
Medical treatment of ectopic pregnancy: a committee opinion
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Predictive value of embryo grading for embryos with known outcomes
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Elizabeth Taylor, M.D., Christina Williams, M.D. 
Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis 
Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M
Oocyte cryopreservation
Robert F. Casper, M.D.  Fertility and Sterility 
Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain  Mohamed A. Bedaiwy,
Bradley J. Van Voorhis, M. D. , Rachel B. Mejia, D. O. , William D
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis  Dimitra Kyrou,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Prolonging oocyte in vitro culture and handling time does not compensate for a shorter interval from human chorionic gonadotropin administration to oocyte.
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Number of good quality embryos on day 3 is predictive for both pregnancy and implantation rates in in vitro fertilization/intracytoplasmic sperm injection.
Jennifer F. Kawwass, M. D. , Sara Crawford, Ph. D. , Donna R
“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss  Michelle.
CDB-2914, a novel selective progesterone receptor modulator, differentially regulates endometrial gene expression in the proliferative phase of the menstrual.
GnRH antagonists may affect endometrial receptivity
Atsushi Yanaihara, M. D. , Ph. D. , Takeshi Yorimitsu, M. D
José Bellver, M. D. , Yanira Ayllón, M. D. , Marcos Ferrando, M. D
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
S. Samuel Kim, M.D.  Fertility and Sterility 
Website quality assessment: Mistaking apples for oranges
Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization–embryo transfer cycle outcome  Eric S Surrey,
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis.
Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis  Byung Chul Jee, M.D., Chang Suk Suh, M.D.,
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization  David W. Schmidt, M.D.,,
Fertility and Sterility: an evaluation
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B
Current evaluation of amenorrhea
A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer  William M. Buckett, M.D.  Fertility and Sterility 
Fertility and Sterility
Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery.
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Defining the proliferative phase endometrial defect
In vitro sildenafil citrate use as a sperm motility stimulant
Soluble HLA-G in the peritoneal fluid of women with endometriosis
Randomized controlled trial: effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization  Irene Moy, M.D., Magdy P. Milad, M.D.,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Endometrial polyps affect uterine receptivity
Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society.
Presentation transcript:

Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?  Eric S. Surrey, M.D., Annette K. Lietz, L.V.N., Robert L. Gustofson, M.D., Debra A. Minjarez, M.D., William B. Schoolcraft, M.D.  Fertility and Sterility  Volume 93, Issue 2, Pages 646-651 (January 2010) DOI: 10.1016/j.fertnstert.2008.12.023 Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Randomization summary of patients eligible to participate in the current trial. Fertility and Sterility 2010 93, 646-651DOI: (10.1016/j.fertnstert.2008.12.023) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Biochemical (Bio), ongoing pregnancy (OPR), and implantation (IR) rates in Groups 1 and 2 with positive endometrial αvβ3 vitronectin expression. Fertility and Sterility 2010 93, 646-651DOI: (10.1016/j.fertnstert.2008.12.023) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Biochemical (Bio), ongoing pregnancy (OPR), and implantation (IR) rates in Groups A and B with negative αvβ3 vitronectin expression. Fertility and Sterility 2010 93, 646-651DOI: (10.1016/j.fertnstert.2008.12.023) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.